Toxoplasmosis in non-cardiac solid organ transplant recipients: A case series and review of literature

Poornima Ramanan, Sias Scherger, Esther Benamu, Valida Bajrovic, Whitney Jackson, Chadi A. Hage, Morgan Hakki, John W. Baddley, Maheen Z. Abidi

Research output: Contribution to journalArticle

1 Scopus citations


The risk of toxoplasmosis in high-risk cardiac transplant recipients is well recognized prompting universal donor and candidate screening with administration of targeted post-transplant chemoprophylaxis in high-risk (D+/R−) cardiac transplant patients. In contrast, until recently, there have been neither well-defined recommendations nor consensus regarding toxoplasmosis preventive strategies among non-cardiac solid organ transplant recipients. We report 3 cases of post-transplant toxoplasmosis in non-cardiac transplant recipients (one lung and two liver); all 3 infections presumed to be donor-derived. Not surprisingly, pre-transplant Toxoplasma serology was negative in all the patients. None of the patients were on trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis at the time of diagnosis of toxoplasmosis. The median time from transplant to onset of infection was 90 days (range: 30-120 days). Clinical presentations included cerebral (n = 1) and disseminated infections (n = 2). Two of the 3 patients, both with disseminated infection died (mortality ~ 67%).

Original languageEnglish (US)
Article numbere13218
JournalTransplant Infectious Disease
Issue number1
StatePublished - Feb 1 2020



  • solid organ transplant recipients
  • toxoplasmosis

ASJC Scopus subject areas

  • Infectious Diseases
  • Transplantation

Cite this

Ramanan, P., Scherger, S., Benamu, E., Bajrovic, V., Jackson, W., Hage, C. A., Hakki, M., Baddley, J. W., & Abidi, M. Z. (2020). Toxoplasmosis in non-cardiac solid organ transplant recipients: A case series and review of literature. Transplant Infectious Disease, 22(1), [e13218].